One of the goals of the project is to create new treatment methods specially designed to fight a specific type of brain cancer (GBM – glioblastoma multiforme). By combining proton radiotherapy, chemotherapy and neutron therapies, we are aiming for revolutionary results.
Our company has become an important part of the European project NuCapCure, focused on developing innovative treatment methods for glioblastoma multiforme (GBM), an aggressive form of brain tumor. This revolutionary initiative aims to address a significant issue in oncology.
The goal of the NuCapCure project is to develop and validate new treatment procedures that will be effective and specifically targeted at GBM. The combination of proton radiotherapy, chemotherapy, and neutron therapies opens up new perspectives in the fight against this malignant disease.
Over the next 54 months, we will collaborate with six other European institutions to develop and validate these treatment procedures. Details about the project can be found in the NuCapCure project press release.
Join us and follow the project's website, where information about progress and other important updates will be continuously added.
